2. Kazemian M R, Solouk A, Tan A, et al. Preventing in-stent restenosis using lipoprotein (a), lipid and cholesterol adsorbent materials. Med Hypotheses, 2015, 85(6): 986-988.
[3]
3. Papafaklis M I, Chatzizisis Y S, Naka K K, et al. Drug-eluting stent restenosis: effect of drug type, release kinetics, hemodynamics and coating strategy. Pharmacol Ther, 2012, 134(1): 43-53.
[4]
4. Lan Hualin, Wang Yi, Yin Tieyin, et al. Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation. J Biomed Mater Res B Appl Biomater, 2015, 104(6): 1237-1247.
[5]
5. Foin N, Torii R, Mattesini A, et al. Biodegradable vascular scaffold:is optimal expansion the key to minimising flow disturbances and risk of adverse events?. EuroIntervention, 2015, 10(10): 1139-1142.
[6]
6. Hu Tingzhang, Yang Jiali, Cui Kun, et al. Controlled Slow-Release Drug-Eluting stents for the prevention of coronary restenosis: recent progress and future prospects. ACS Appl Mater Interfaces, 2015, 7(22): 11695-11712.
[7]
7. Mcginty S, Mckee S, Mccormick C, et al. Release mechanism and parameter estimation in drug-eluting stent systems: analytical solutions of drug release and tissue transport. Math Med Biol, 2015, 32(2): 163-186.
[8]
8. Wilson H K, Canfield S G, Hjortness M K, et al. Exploring the effects of cell seeding density on the differentiation of human pluripotent stem cells to brain microvascular endothelial cells. Fluids Barriers CNS, 2015, 12: 13.
10. Dan P, Velot E, Decot V, et al. The role of mechanical stimuli in the vascular differentiation of mesenchymal stem cells. J Cell Sci, 2015, 128(14): 2415-2422.
[11]
11. Yu Baoqi, Wong M M, Potter C M, et al. Vascular stem/progenitor cell migration induced by smooth muscle Cell-Derived chemokine (C-C motif) ligand 2 and chemokine (C-X-C motif) ligand 1 contributes to neointima formation. Stem Cells, 2016, 34(9): 2368-2380.
[12]
12. Campagnolo P, Hong Xuechong, Di Bernardini E A, et al. Resveratrol-Induced vascular progenitor differentiation towards endothelial lineage via MiR-21/Akt/beta-Catenin is protective in vessel graft models. PLoS One, 2015, 10(5): UNSP e0125122.
[13]
13. Liu Junfeng, Chen Zhi, Du Zhongdong, et al. Granulocyte colony-stimulating factor ameliorates coronary artery elastin breakdown in a mouse model of Kawasaki disease. Chin Med J: Engl, 2014, 127(21): 3712-3717.
15. Poh C K, Shi Zhilong, Lim T Y, et al. The effect of VEGF functionalization of Titanium on endothelial cells in vitro. Biomaterials, 2010, 31(7): 1578-1585.
[16]
16. Song Chunli, Li Qian, Yu Yunpeng, et al. Study of novel coating strategy for coronary stents: simutaneous coating of VEGF and anti-CD34 antibody. Rev Bras Cir Cardiovasc, 2015, 30(2): 159-163.
18. Saito N, Mori Y, Uchiyama S. Drug diffusion and biological responses of arteries using a drug-eluting stent with nonuniform coating. Med Devices: Evidence and Research, 2016, 9: 33-43.
[19]
19. Zhu Jinzhou, Liu Huizhu, Cui Haipo, et al. Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent. J Mater Sci Mater Med, 2017, 28(3): 54.
23. Kubasek J, Vojtech D, Jablonska E, et al. Structure, mechanical characteristics and in vitro degradation, cytotoxicity, genotoxicity and mutagenicity of novel biodegradable Zn-Mg alloys. Mater Sci Eng C Mater Biol Appl, 2016, 58: 24-35.
[24]
24. Bowen P K, Guillory I R, Shearier E R, et al. Metallic Zinc exhibits optimal biocompatibility for bioabsorbable endovascular stents. Mater Sci Eng C Mater Biol Appl, 2015, 56: 467-472.
[25]
25. Wu X, Zhao Y, Tang C, et al. Re-endothelialization study on endovascular stents seeded by endothelial cells through up-or downregulation of VEGF. ACS Appl Mater Interfaces, 2016, 8(11): 7578-7589.
[26]
26. Shirota T, Yasui H, Shimokawa H, et al. Fabrication of endothelial progenitor cell(EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials, 2003, 24(13): 2295-2302.
[27]
27. Hwang C W, Johnston P V, Gerstenblith G, et al. Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors. Biomaterials, 2015, 52: 318-326.
[28]
28. Wu Xue, Yin Tieying, Tian Jie, et al. Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injury. Regenerative Biomaterials, 2015, 2(2): 87-96.
